MX2016008070A - Sistemas de administracion de farmaco. - Google Patents

Sistemas de administracion de farmaco.

Info

Publication number
MX2016008070A
MX2016008070A MX2016008070A MX2016008070A MX2016008070A MX 2016008070 A MX2016008070 A MX 2016008070A MX 2016008070 A MX2016008070 A MX 2016008070A MX 2016008070 A MX2016008070 A MX 2016008070A MX 2016008070 A MX2016008070 A MX 2016008070A
Authority
MX
Mexico
Prior art keywords
delivery systems
drug delivery
peptide
thermogelling
chitosan
Prior art date
Application number
MX2016008070A
Other languages
English (en)
Inventor
Supper Stephanie
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MX2016008070A publication Critical patent/MX2016008070A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6903—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being semi-solid, e.g. an ointment, a gel, a hydrogel or a solidifying gel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a sistemas de suministro de un péptido termogelificante que se inyectan como un sol líquido a temperatura ambiente a través de agujas de inyección finas y se transforman en un gel altamente viscoso, una vez que es insertado en el tejido caliente del cuerpo humano o animal. En una modalidad preferida, dicho sistema se basa en el uso de un péptido hidrófobo, un quitosano y una glucosa-fosfato.
MX2016008070A 2013-12-19 2014-12-17 Sistemas de administracion de farmaco. MX2016008070A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361918378P 2013-12-19 2013-12-19
PCT/IB2014/066986 WO2015092690A1 (en) 2013-12-19 2014-12-17 Drug delivery systems

Publications (1)

Publication Number Publication Date
MX2016008070A true MX2016008070A (es) 2017-05-12

Family

ID=52278686

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016008070A MX2016008070A (es) 2013-12-19 2014-12-17 Sistemas de administracion de farmaco.

Country Status (11)

Country Link
US (4) US20180133147A1 (es)
EP (1) EP3082765B1 (es)
JP (1) JP6813357B2 (es)
KR (1) KR20160098258A (es)
CN (1) CN105828803B (es)
AU (2) AU2014369213B2 (es)
CA (1) CA2929117A1 (es)
ES (1) ES2693523T3 (es)
MX (1) MX2016008070A (es)
RU (1) RU2016129138A (es)
WO (1) WO2015092690A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10576099B2 (en) 2016-10-21 2020-03-03 Covidien Lp Injectable scaffold for treatment of intracranial aneurysms and related technology
KR102289626B1 (ko) * 2019-10-31 2021-08-12 경희대학교 산학협력단 숙신화 키토산 하이드로겔의 제조방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2212300A1 (en) 1997-08-04 1999-02-04 Abdellatif Chenite In vitro or in vivo gelfying chitosan and therapeutic uses thereof
GB0018891D0 (en) 2000-08-01 2000-09-20 Novartis Ag Organic compounds
US7261427B1 (en) * 2004-02-20 2007-08-28 Magna Donnelly Mirrors North America L.L.C. Twin-arm vehicle mirror system with support bracket bearings
GB0403938D0 (en) * 2004-02-21 2004-03-24 West Pharm Serv Drug Res Ltd Chitosan containing solution
JP5746617B2 (ja) * 2008-06-11 2015-07-08 チ２ジェル リミテッドＣｈｉ２Ｇｅｌ Ｌｔｄ． キトサン混合物を形成する注入可能なヒドロゲル
CN101502673A (zh) * 2009-03-05 2009-08-12 大连理工大学 一种可注射壳聚糖/甘油磷酸钠/胶原水凝胶的制备方法
CN102125516B (zh) * 2010-01-13 2014-03-26 北京大学 温敏型原位凝胶药物组合物

Also Published As

Publication number Publication date
JP2016540813A (ja) 2016-12-28
US20210128455A1 (en) 2021-05-06
RU2016129138A (ru) 2018-01-24
US20200060965A1 (en) 2020-02-27
EP3082765B1 (en) 2018-08-01
US20180133147A1 (en) 2018-05-17
CN105828803A (zh) 2016-08-03
CN105828803B (zh) 2019-06-07
ES2693523T3 (es) 2018-12-12
CA2929117A1 (en) 2015-06-25
AU2014369213B2 (en) 2017-10-19
AU2014369213A1 (en) 2016-05-19
JP6813357B2 (ja) 2021-01-13
KR20160098258A (ko) 2016-08-18
EP3082765A1 (en) 2016-10-26
WO2015092690A1 (en) 2015-06-25
AU2017239503A1 (en) 2017-10-26
US20240009115A1 (en) 2024-01-11

Similar Documents

Publication Publication Date Title
MX2023003211A (es) Sistema de suministro de farmacos controlable y metodo de uso.
MX2020003329A (es) Inyector y metodo de montaje.
EA201600139A1 (ru) Прибор для инъекций с минимальным захватом и его использование
WO2017070391A3 (en) Injection system
EP3666322C0 (en) HEART VALVE DELIVERY CATHETER AND ASSOCIATED SYSTEM
WO2014160804A3 (en) Systems and methods using microneedles
CR20160104A (es) Dispositivo de estabilización de conexión de catéter y procedimientos de uso del mismo
MX2021012349A (es) Dispositivos y metodos de unidades multiples para administracion de farmacos.
EP3167393A4 (en) Medicine administering system including injection pen and companion device
BR112015019641A2 (pt) sistemas de entrega de endoprótese com a implantação adicional
BR112015021446A2 (pt) métodos cirúrgicos empregando composições de peptídeo amfifílico purificado
EP4279109A3 (en) Headgear for a patient interface
WO2015095624A3 (en) Drug mixing and delivery system and method
EP3409308A4 (en) COVER AND MEDICAL LIQUID INJECTION DEVICE THEREFOR
EP3064240A4 (en) Needle-equipped sysringe, pre-filled syringe, and medical liquid administration device using same
EP3277338A4 (en) Cannula system with sterile connector, blood pump, and patient harness
AU201716352S (en) Drug infusion device
EP2777726A3 (en) Medical devices
BR112016002251A2 (pt) dispositivo para administração de fármacos
AU201611753S (en) Connector holder for a medical delivery device
AU364942S (en) Garment with carrying case for medical delivery device
BR112015024464A2 (pt) dispositivo de infusão com estrutura em camadas tendo componentes duráveis e descartáveis
WO2016060918A3 (en) Formulations for histatin therapeutics
WO2014113384A8 (en) Lacrimal system drug delivery device
EP3641849C0 (en) SYSTEMS AND METHODS FOR INCORPORATING PATIENT PRESSURE INTO A MEDICAL FLUID DELIVERY SYSTEM